Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature

被引:352
作者
Ammassari, A
Trotta, MP
Murri, R
Castelli, F
Narciso, P
Noto, P
Vecchiet, J
D'Arminio Monforte, A
Wu, AW
Antinori, A
机构
[1] Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy
[2] L Spallanzani IRCCS, Ist Nazl Malattie Infett, Rome, Italy
[3] Univ Brescia, Ist Malattie Infett & Trop, I-25121 Brescia, Italy
[4] Univ Chieti, Clin Malattie Infett, Chieti, Italy
[5] Univ Milan, Ist Malattie Infett & Trop, I-20122 Milan, Italy
[6] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21218 USA
关键词
adherence; compliance; HIV/AIDS; antiretroviral therapy; HAART;
D O I
10.1097/00126334-200212153-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Knowledge of factors associated with medication adherence could help HIV clinicians to target persons in need of intervention, design these interventions, and help researchers to plan studies of adherence. This review summarizes the results of 20 studies investigating the issue of barriers to optimal highly active antiretroviral therapy (HAART) adherence. Only a few determinants were consistently associated with nonadherence. Symptoms and adverse drug effects, psychologic distress, lack of social or family support, complexity of the HAART regimen, low patient self-efficacy, and inconvenience of treatment were the factors most consistently associated with nonadherence. There were inconsistent findings regarding the relationship of adherence,and the following variables: sociodemographic characteristics, substance abuse, depressive symptoms, quality of life, CD4(+) cell count, knowledge and beliefs about treatment, patients' satisfaction with health care, and patient-provider relationship. A synthesis of findings relating various factors to adherence to HAART is difficult to reach because of several limitations of the existing body of research. These limitations concern the measurement of adherence, the assessment of correlates and predictors of adherence, the study population, and the study design.
引用
收藏
页码:S123 / S127
页数:5
相关论文
共 29 条
  • [1] Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008
  • [2] Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006
  • [3] Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring
    Arnsten, JH
    Demas, PA
    Farzadegan, H
    Grant, RW
    Gourevitch, MN
    Chang, CJ
    Buono, D
    Eckholdt, H
    Howard, AA
    Schoenbaum, EE
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1417 - 1423
  • [4] Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
    Bangsberg, DR
    Hecht, FM
    Charlebois, ED
    Zolopa, AR
    Holodniy, M
    Sheiner, L
    Bamberger, JD
    Chesney, MA
    Moss, A
    [J]. AIDS, 2000, 14 (04) : 357 - 366
  • [5] Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005
  • [6] Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease
    Catz, SL
    Kelly, JA
    Bogart, LM
    Benotsch, EG
    McAuliffe, TL
    [J]. HEALTH PSYCHOLOGY, 2000, 19 (02) : 124 - 133
  • [7] Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments
    Chesney, MA
    Ickovics, JR
    Chambers, DB
    Gifford, AL
    Neidig, J
    Zwickl, B
    Wu, AW
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03): : 255 - 266
  • [8] Duran S, 2001, HIV Clin Trials, V2, P38
  • [9] Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease
    Eldred, LJ
    Wu, AW
    Chaisson, RE
    Moore, RD
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (02) : 117 - 125
  • [10] Gallant J E, 1998, J Int Assoc Physicians AIDS Care, V4, P32